BCL11A intellectual developmental disorder: defining the clinical spectrum and genotype-phenotype correlations

Angela Peron, Felice D’Arco, Kimberly A. Aldinger, Constance Smith-Hicks, Christiane Zweier, Gyri A. Gradek, Kimberley Bradbury, Andrea Accogli, Erica F. Andersen, Ping Yee Billie Au, Roberta Battini, Daniah Beleford, Lynne M. Bird, Arjan Bouman, Ange-Line Bruel, Øyvind Løvold Busk, Philippe M. Campeau, Valeria Capra, Colleen Carlston, Jenny CarmichaelAnna Chassevent, Jill Clayton-Smith, Michael J. Bamshad, Dawn L. Earl, Laurence Faivre, Christophe Philippe, Patrick Ferreira, Luitgard Graul-Neumann, Mary J. Green, Darrah Haffner, Parthiv Haldipur, Suhair Hanna, Gunnar Houge, Wendy D. Jones, Cornelia Kraus, Birgit Elisabeth Kristiansen, James Lespinasse, Karen J. Low, Sally Ann Lynch, Sofia Maia, Rong Mao, Ruta Kalinauskiene, Catherine Melver, Kimberly Mcdonald, Tara Montgomery, Manuela Morleo, Constance Motter, Amanda S. Openshaw, Janice Cox Palumbos, Aditi Shah Parikh, Yezmin Perilla-Young, Cynthia M. Powell, Richard Person, Megha Desai, Juliette Piard, Rolph Pfundt, Marcello Scala, Margaux Serey-Gaut, Deborah Shears, Anne Slavotinek, Mohnish Suri, Claire Turner, Tatiana Tvrdik, Karin Weiss, Ingrid M. Wentzensen, Marcella Zollino, Tzung-Chien Hsieh, Keri Ramsey, Marcella Zollino, Marcello Scala, Valeria Capra, Angela Peron, Bert B. A. De Vries, Francois Guillemot, William B. Dobyns, David Viskochil, Cristina Dias

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

An increasing number of individuals with intellectual developmental disorder (IDD) and heterozygous variants in BCL11A are identified, yet our knowledge of manifestations and mutational spectrum is lacking. To address this, we performed detailed analysis of 42 individuals with BCL11A-related IDD (BCL11A-IDD, a.k.a. Dias-Logan syndrome) ascertained through an international collaborative network, and reviewed 35 additional previously reported patients. Analysis of 77 affected individuals identified 60 unique disease-causing variants (30 frameshift, 7 missense, 6 splice-site, 17 stop-gain) and 8 unique BCL11A microdeletions. We define the most prevalent features of BCL11A-IDD: IDD, postnatal-onset microcephaly, hypotonia, behavioral abnormalities, autism spectrum disorder, and persistence of fetal hemoglobin (HbF), and identify autonomic dysregulation as new feature. BCL11A-IDD is distinguished from 2p16 microdeletion syndrome, which has a higher incidence of congenital anomalies. Our results underscore BCL11A as an important transcription factor in human hindbrain development, identifying a previously underrecognized phenotype of a small brainstem with a reduced pons/medulla ratio. Genotype-phenotype correlation revealed an isoform-dependent trend in severity of truncating variants: those affecting all isoforms are associated with higher frequency of hypotonia, and those affecting the long (BCL11A-L) and extra-long (-XL) isoforms, sparing the short (-S), are associated with higher frequency of postnatal microcephaly. With the largest international cohort to date, this study highlights persistence of fetal hemoglobin as a consistent biomarker and hindbrain abnormalities as a common feature. It contributes significantly to our understanding of BCL11A-IDD through an extensive unbiased multi-center assessment, providing valuable insights for diagnosis, management and counselling, and into BCL11A’s role in brain development.
Lingua originaleEnglish
pagine (da-a)N/A-N/A
RivistaEuropean Journal of Human Genetics
DOI
Stato di pubblicazionePubblicato - 2024

Keywords

  • BCL11A-Related Intellectual Disability

Fingerprint

Entra nei temi di ricerca di 'BCL11A intellectual developmental disorder: defining the clinical spectrum and genotype-phenotype correlations'. Insieme formano una fingerprint unica.

Cita questo